OLE: Biohaven Rise 2
Enrolling By Invitation
99 years or below
All
Phase
N/A
2 participants needed
1 Location
Brief description of study
Open label extension of RISE, a study of BHV7000 in patients 18+ with focal epilepsy.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Updated on
14 Nov 2024.
Study ID: 856700
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
